Author

Md Qudratullah

The University of Texas MD Anderson Cancer CenterORCID 0009-0008-6580-5367Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Yonathan LissanuiD· 2 shared Eiru KimiD· 1 shared Iqbal MahmudiD· 1 shared Ismail Mustafa MeraziD· 1 shared Jack A. RothiD· 1 shared Jing WangiD· 1 shared Kadir Caner AkdemiriD· 1 shared Lin Tan· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Yonathan LissanuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCancer ResearchPeer-reviewedMar 13, 2025

SMARCA4 mutation induces tumor cell-intrinsic defects in enhancer landscape and resistance to immunotherapy

Yawen Wang, Ismail Mustafa Meraz, Md Qudratullah…·Yonathan Lissanu

This study shows that SMARCA4 mutations in lung cancer disrupt enhancer landscapes and innate immune gene expression, leading to immunotherapy resistance.

29 citationstop 2%

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 16, 2024

Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activity

Nicholas Blazanin, Xiaobing Liang, Iqbal Mahmud…·Yonathan Lissanu

This study identifies ROCK inhibition as a strategy to overcome metabolic adaptation in cancer cells to OXPHOS inhibition, showing synergistic anti-tumor effects.

5 citations

humanproteomics

𝕏 PostBluesky